https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:40Z', 'uri': 'http://wayback.archive-it.org/all/20160930161440/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2016-09-30T16:14:40Z', 'uri': 'http://web.archive.org/web/20160930161440/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2017-07-14T10:51:10Z', 'uri': 'http://web.archive.org/web/20170714105110/https://guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2017-10-02T19:59:42Z', 'uri': 'http://wayback.archive-it.org/all/20171002195942/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2017-10-02T19:59:42Z', 'uri': 'http://web.archive.org/web/20171002195942/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2018-04-13T18:48:07Z', 'uri': 'http://wayback.archive-it.org/all/20180413184807/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2018-04-13T18:48:07Z', 'uri': 'http://web.archive.org/web/20180413184807/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2018-05-18T21:42:44Z', 'uri': 'http://wayback.archive-it.org/all/20180518214244/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2018-05-18T21:42:44Z', 'uri': 'http://web.archive.org/web/20180518214244/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2018-06-09T11:34:01Z', 'uri': 'http://web.archive.org/web/20180609113401/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}, {'datetime': '2018-07-12T18:31:29Z', 'uri': 'http://web.archive.org/web/20180712183129/https://www.guideline.gov/expert/expert-commentary/16436/using-grade-for-international-guidelines-on-kidney-disease'}]
https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:45Z', 'uri': 'http://wayback.archive-it.org/all/20160930161445/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2016-09-30T16:14:45Z', 'uri': 'http://web.archive.org/web/20160930161445/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2017-07-14T10:31:31Z', 'uri': 'http://web.archive.org/web/20170714103131/https://guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2017-10-02T19:59:47Z', 'uri': 'http://wayback.archive-it.org/all/20171002195947/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2017-10-02T19:59:47Z', 'uri': 'http://web.archive.org/web/20171002195947/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2018-04-13T18:48:13Z', 'uri': 'http://wayback.archive-it.org/all/20180413184813/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2018-04-13T18:48:13Z', 'uri': 'http://web.archive.org/web/20180413184813/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2018-05-18T21:42:49Z', 'uri': 'http://wayback.archive-it.org/all/20180518214249/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2018-05-18T21:42:49Z', 'uri': 'http://web.archive.org/web/20180518214249/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2018-06-09T11:34:06Z', 'uri': 'http://web.archive.org/web/20180609113406/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}, {'datetime': '2018-07-12T18:31:32Z', 'uri': 'http://web.archive.org/web/20180712183132/https://www.guideline.gov/expert/expert-commentary/16437/the-many-facets-of-evidence-commentary-on-the-american-academy-of-neurologys-evidence-classification-scheme'}]
https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:50Z', 'uri': 'http://wayback.archive-it.org/all/20160930161450/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2016-09-30T16:14:50Z', 'uri': 'http://web.archive.org/web/20160930161450/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2017-07-14T11:20:49Z', 'uri': 'http://web.archive.org/web/20170714112049/https://guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2017-10-02T19:59:53Z', 'uri': 'http://wayback.archive-it.org/all/20171002195953/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2017-10-02T19:59:53Z', 'uri': 'http://web.archive.org/web/20171002195953/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2018-04-13T18:48:17Z', 'uri': 'http://wayback.archive-it.org/all/20180413184817/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2018-04-13T18:48:17Z', 'uri': 'http://web.archive.org/web/20180413184817/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2018-05-18T21:42:55Z', 'uri': 'http://wayback.archive-it.org/all/20180518214255/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2018-05-18T21:42:55Z', 'uri': 'http://web.archive.org/web/20180518214255/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2018-06-09T11:34:08Z', 'uri': 'http://web.archive.org/web/20180609113408/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}, {'datetime': '2018-07-12T18:31:28Z', 'uri': 'http://web.archive.org/web/20180712183128/https://www.guideline.gov/expert/expert-commentary/16438/commentary-on-the-american-college-of-physicians-clinical-practice-guidelines-for-using-secondgeneration-antidepressants-to-treat-depressive-disorders'}]
https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:54Z', 'uri': 'http://wayback.archive-it.org/all/20160930161454/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2016-09-30T16:14:54Z', 'uri': 'http://web.archive.org/web/20160930161454/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2017-07-14T11:33:23Z', 'uri': 'http://web.archive.org/web/20170714113323/https://guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2017-10-02T19:59:58Z', 'uri': 'http://wayback.archive-it.org/all/20171002195958/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2017-10-02T19:59:58Z', 'uri': 'http://web.archive.org/web/20171002195958/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2018-04-13T18:48:22Z', 'uri': 'http://wayback.archive-it.org/all/20180413184822/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2018-04-13T18:48:22Z', 'uri': 'http://web.archive.org/web/20180413184822/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2018-05-18T21:43:01Z', 'uri': 'http://wayback.archive-it.org/all/20180518214301/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2018-05-18T21:43:01Z', 'uri': 'http://web.archive.org/web/20180518214301/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2018-06-09T11:33:59Z', 'uri': 'http://web.archive.org/web/20180609113359/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}, {'datetime': '2018-07-12T18:30:36Z', 'uri': 'http://web.archive.org/web/20180712183036/https://www.guideline.gov/expert/expert-commentary/16439/on-quality-measurement-babies-and-bathwater'}]
https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:59Z', 'uri': 'http://wayback.archive-it.org/all/20160930161459/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2016-09-30T16:14:59Z', 'uri': 'http://web.archive.org/web/20160930161459/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2017-07-14T11:45:01Z', 'uri': 'http://web.archive.org/web/20170714114501/https://guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2017-10-02T20:00:03Z', 'uri': 'http://wayback.archive-it.org/all/20171002200003/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2017-10-02T20:00:03Z', 'uri': 'http://web.archive.org/web/20171002200003/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2018-04-13T18:48:27Z', 'uri': 'http://wayback.archive-it.org/all/20180413184827/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2018-04-13T18:48:27Z', 'uri': 'http://web.archive.org/web/20180413184827/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2018-05-18T21:43:07Z', 'uri': 'http://wayback.archive-it.org/all/20180518214307/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2018-05-18T21:43:07Z', 'uri': 'http://web.archive.org/web/20180518214307/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2018-06-09T11:34:05Z', 'uri': 'http://web.archive.org/web/20180609113405/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}, {'datetime': '2018-07-12T18:31:41Z', 'uri': 'http://web.archive.org/web/20180712183141/https://www.guideline.gov/expert/expert-commentary/16440/new-promise-for-uniform-evidencebased-guideline-development-the-grade-approach'}]
https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:04Z', 'uri': 'http://wayback.archive-it.org/all/20160930161504/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2016-09-30T16:15:04Z', 'uri': 'http://web.archive.org/web/20160930161504/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2017-07-14T11:34:14Z', 'uri': 'http://web.archive.org/web/20170714113414/https://guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2017-10-02T20:00:08Z', 'uri': 'http://wayback.archive-it.org/all/20171002200008/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2017-10-02T20:00:08Z', 'uri': 'http://web.archive.org/web/20171002200008/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2018-04-13T18:48:33Z', 'uri': 'http://wayback.archive-it.org/all/20180413184833/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2018-04-13T18:48:33Z', 'uri': 'http://web.archive.org/web/20180413184833/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2018-05-18T21:43:13Z', 'uri': 'http://wayback.archive-it.org/all/20180518214313/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2018-05-18T21:43:13Z', 'uri': 'http://web.archive.org/web/20180518214313/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2018-06-09T11:34:02Z', 'uri': 'http://web.archive.org/web/20180609113402/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}, {'datetime': '2018-07-12T18:31:10Z', 'uri': 'http://web.archive.org/web/20180712183110/https://www.guideline.gov/expert/expert-commentary/16441/user-perspectives-an-overview-of-the-clearinghouse-survey-results'}]
https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:13Z', 'uri': 'http://wayback.archive-it.org/all/20160930161513/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2016-09-30T16:15:13Z', 'uri': 'http://web.archive.org/web/20160930161513/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2017-07-14T10:44:48Z', 'uri': 'http://web.archive.org/web/20170714104448/https://guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2017-10-02T20:00:16Z', 'uri': 'http://wayback.archive-it.org/all/20171002200016/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2017-10-02T20:00:16Z', 'uri': 'http://web.archive.org/web/20171002200016/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2018-04-13T18:48:45Z', 'uri': 'http://wayback.archive-it.org/all/20180413184845/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2018-04-13T18:48:45Z', 'uri': 'http://web.archive.org/web/20180413184845/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2018-05-18T21:43:25Z', 'uri': 'http://wayback.archive-it.org/all/20180518214325/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2018-05-18T21:43:25Z', 'uri': 'http://web.archive.org/web/20180518214325/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2018-06-09T11:34:03Z', 'uri': 'http://web.archive.org/web/20180609113403/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}, {'datetime': '2018-07-12T18:31:45Z', 'uri': 'http://web.archive.org/web/20180712183145/https://www.guideline.gov/expert/expert-commentary/16442/towards-a-better-value-health-system--the-role-of-nice-in-the-uk-health-care-system'}]
https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:21Z', 'uri': 'http://wayback.archive-it.org/all/20160930161521/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2016-09-30T16:15:21Z', 'uri': 'http://web.archive.org/web/20160930161521/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2017-07-14T11:29:38Z', 'uri': 'http://web.archive.org/web/20170714112938/https://guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2017-10-02T20:00:22Z', 'uri': 'http://wayback.archive-it.org/all/20171002200022/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2017-10-02T20:00:22Z', 'uri': 'http://web.archive.org/web/20171002200022/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2018-04-13T18:48:50Z', 'uri': 'http://wayback.archive-it.org/all/20180413184850/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2018-04-13T18:48:50Z', 'uri': 'http://web.archive.org/web/20180413184850/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2018-05-18T21:43:31Z', 'uri': 'http://wayback.archive-it.org/all/20180518214331/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2018-05-18T21:43:31Z', 'uri': 'http://web.archive.org/web/20180518214331/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2018-06-09T11:34:04Z', 'uri': 'http://web.archive.org/web/20180609113404/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}, {'datetime': '2018-07-12T18:31:04Z', 'uri': 'http://web.archive.org/web/20180712183104/https://www.guideline.gov/expert/expert-commentary/16443/comparison-of-multiple-sclerosis-guidelines-underscores-need-for-collaboration'}]
https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:26Z', 'uri': 'http://wayback.archive-it.org/all/20160930161526/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2016-09-30T16:15:26Z', 'uri': 'http://web.archive.org/web/20160930161526/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2017-07-14T10:42:25Z', 'uri': 'http://web.archive.org/web/20170714104225/https://guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2017-10-02T20:00:26Z', 'uri': 'http://wayback.archive-it.org/all/20171002200026/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2017-10-02T20:00:26Z', 'uri': 'http://web.archive.org/web/20171002200026/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2018-04-13T18:48:55Z', 'uri': 'http://wayback.archive-it.org/all/20180413184855/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2018-04-13T18:48:55Z', 'uri': 'http://web.archive.org/web/20180413184855/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2018-05-18T21:43:36Z', 'uri': 'http://wayback.archive-it.org/all/20180518214336/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2018-05-18T21:43:36Z', 'uri': 'http://web.archive.org/web/20180518214336/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2018-06-09T11:34:02Z', 'uri': 'http://web.archive.org/web/20180609113402/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}, {'datetime': '2018-07-12T18:31:33Z', 'uri': 'http://web.archive.org/web/20180712183133/https://www.guideline.gov/expert/expert-commentary/16444/endocarditis-prophylaxis-reexamining-the-evidence'}]
https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:31Z', 'uri': 'http://wayback.archive-it.org/all/20160930161531/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2016-09-30T16:15:31Z', 'uri': 'http://web.archive.org/web/20160930161531/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2017-07-14T11:07:52Z', 'uri': 'http://web.archive.org/web/20170714110752/https://guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2017-10-02T20:00:30Z', 'uri': 'http://wayback.archive-it.org/all/20171002200030/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2017-10-02T20:00:30Z', 'uri': 'http://web.archive.org/web/20171002200030/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2018-04-13T18:49:02Z', 'uri': 'http://wayback.archive-it.org/all/20180413184902/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2018-04-13T18:49:02Z', 'uri': 'http://web.archive.org/web/20180413184902/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2018-05-18T21:43:41Z', 'uri': 'http://wayback.archive-it.org/all/20180518214341/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2018-05-18T21:43:41Z', 'uri': 'http://web.archive.org/web/20180518214341/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2018-06-09T11:34:07Z', 'uri': 'http://web.archive.org/web/20180609113407/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}, {'datetime': '2018-07-12T18:30:42Z', 'uri': 'http://web.archive.org/web/20180712183042/https://www.guideline.gov/expert/expert-commentary/16445/can-guidelines-addressing-resource-allocation-improve-breast-health-outcome-for-low-and-middle-income-countries'}]
https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:36Z', 'uri': 'http://wayback.archive-it.org/all/20160930161536/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2016-09-30T16:15:36Z', 'uri': 'http://web.archive.org/web/20160930161536/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2017-07-14T11:29:04Z', 'uri': 'http://web.archive.org/web/20170714112904/https://guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2017-10-02T20:00:34Z', 'uri': 'http://wayback.archive-it.org/all/20171002200034/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2017-10-02T20:00:34Z', 'uri': 'http://web.archive.org/web/20171002200034/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2018-04-13T18:49:08Z', 'uri': 'http://wayback.archive-it.org/all/20180413184908/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2018-04-13T18:49:08Z', 'uri': 'http://web.archive.org/web/20180413184908/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2018-05-18T21:43:47Z', 'uri': 'http://wayback.archive-it.org/all/20180518214347/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2018-05-18T21:43:47Z', 'uri': 'http://web.archive.org/web/20180518214347/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2018-06-09T11:34:06Z', 'uri': 'http://web.archive.org/web/20180609113406/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}, {'datetime': '2018-07-12T18:31:09Z', 'uri': 'http://web.archive.org/web/20180712183109/https://www.guideline.gov/expert/expert-commentary/16446/a-guideline-for-palliative-and-end-of-life-care'}]
https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:40Z', 'uri': 'http://wayback.archive-it.org/all/20160930161540/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2016-09-30T16:15:40Z', 'uri': 'http://web.archive.org/web/20160930161540/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2017-07-14T10:05:41Z', 'uri': 'http://web.archive.org/web/20170714100541/https://guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2017-10-02T20:00:39Z', 'uri': 'http://wayback.archive-it.org/all/20171002200039/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2017-10-02T20:00:39Z', 'uri': 'http://web.archive.org/web/20171002200039/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2018-04-13T18:49:12Z', 'uri': 'http://wayback.archive-it.org/all/20180413184912/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2018-04-13T18:49:12Z', 'uri': 'http://web.archive.org/web/20180413184912/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2018-05-18T21:43:54Z', 'uri': 'http://wayback.archive-it.org/all/20180518214354/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2018-05-18T21:43:54Z', 'uri': 'http://web.archive.org/web/20180518214354/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2018-06-09T11:34:03Z', 'uri': 'http://web.archive.org/web/20180609113403/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}, {'datetime': '2018-07-12T18:30:32Z', 'uri': 'http://web.archive.org/web/20180712183032/https://www.guideline.gov/expert/expert-commentary/16447/the-american-heart-associations-get-with-the-guidelines-program-key-findings-and-lessons-learned'}]
https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:45Z', 'uri': 'http://wayback.archive-it.org/all/20160930161545/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2016-09-30T16:15:45Z', 'uri': 'http://web.archive.org/web/20160930161545/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2017-07-14T11:03:02Z', 'uri': 'http://web.archive.org/web/20170714110302/https://guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2017-10-02T20:00:45Z', 'uri': 'http://wayback.archive-it.org/all/20171002200045/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2017-10-02T20:00:45Z', 'uri': 'http://web.archive.org/web/20171002200045/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2018-04-13T18:49:17Z', 'uri': 'http://wayback.archive-it.org/all/20180413184917/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2018-04-13T18:49:17Z', 'uri': 'http://web.archive.org/web/20180413184917/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2018-05-18T21:43:59Z', 'uri': 'http://wayback.archive-it.org/all/20180518214359/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2018-05-18T21:43:59Z', 'uri': 'http://web.archive.org/web/20180518214359/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2018-06-09T11:34:07Z', 'uri': 'http://web.archive.org/web/20180609113407/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}, {'datetime': '2018-07-12T18:31:31Z', 'uri': 'http://web.archive.org/web/20180712183131/https://www.guideline.gov/expert/expert-commentary/16448/building-a-better-guideline-overcoming-challenges-and-establishing-transparency'}]
https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:49Z', 'uri': 'http://wayback.archive-it.org/all/20160930161549/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2016-09-30T16:15:49Z', 'uri': 'http://web.archive.org/web/20160930161549/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2017-07-14T10:34:28Z', 'uri': 'http://web.archive.org/web/20170714103428/https://guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2017-10-02T20:00:50Z', 'uri': 'http://wayback.archive-it.org/all/20171002200050/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2017-10-02T20:00:50Z', 'uri': 'http://web.archive.org/web/20171002200050/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2018-04-13T18:49:22Z', 'uri': 'http://wayback.archive-it.org/all/20180413184922/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2018-04-13T18:49:22Z', 'uri': 'http://web.archive.org/web/20180413184922/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2018-05-18T21:44:05Z', 'uri': 'http://wayback.archive-it.org/all/20180518214405/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2018-05-18T21:44:05Z', 'uri': 'http://web.archive.org/web/20180518214405/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2018-06-09T11:34:05Z', 'uri': 'http://web.archive.org/web/20180609113405/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}, {'datetime': '2018-07-12T18:31:08Z', 'uri': 'http://web.archive.org/web/20180712183108/https://www.guideline.gov/expert/expert-commentary/16449/is-the-measurement-mandate-diverting-the-patient-safety-revolution'}]
https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:54Z', 'uri': 'http://wayback.archive-it.org/all/20160930161554/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2016-09-30T16:15:54Z', 'uri': 'http://web.archive.org/web/20160930161554/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2017-07-14T09:55:00Z', 'uri': 'http://web.archive.org/web/20170714095500/https://guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2017-10-02T20:00:54Z', 'uri': 'http://wayback.archive-it.org/all/20171002200054/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2017-10-02T20:00:54Z', 'uri': 'http://web.archive.org/web/20171002200054/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2018-04-13T18:49:28Z', 'uri': 'http://wayback.archive-it.org/all/20180413184928/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2018-04-13T18:49:28Z', 'uri': 'http://web.archive.org/web/20180413184928/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2018-05-18T21:44:12Z', 'uri': 'http://wayback.archive-it.org/all/20180518214412/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2018-05-18T21:44:12Z', 'uri': 'http://web.archive.org/web/20180518214412/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2018-06-09T11:34:05Z', 'uri': 'http://web.archive.org/web/20180609113405/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}, {'datetime': '2018-07-12T18:31:50Z', 'uri': 'http://web.archive.org/web/20180712183150/https://www.guideline.gov/expert/expert-commentary/16450/eating-disorders-newer-practice-guidelines-reinforce-severity-of-conditions-but-still-reflect-deficits-in-knowledge-base'}]
https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:16:04Z', 'uri': 'http://wayback.archive-it.org/all/20160930161604/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2016-09-30T16:16:04Z', 'uri': 'http://web.archive.org/web/20160930161604/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2017-07-14T10:34:19Z', 'uri': 'http://web.archive.org/web/20170714103419/https://guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2017-10-02T20:01:23Z', 'uri': 'http://wayback.archive-it.org/all/20171002200123/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2017-10-02T20:01:23Z', 'uri': 'http://web.archive.org/web/20171002200123/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2018-04-13T18:49:39Z', 'uri': 'http://wayback.archive-it.org/all/20180413184939/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2018-04-13T18:49:39Z', 'uri': 'http://web.archive.org/web/20180413184939/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2018-05-18T21:44:24Z', 'uri': 'http://wayback.archive-it.org/all/20180518214424/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2018-05-18T21:44:24Z', 'uri': 'http://web.archive.org/web/20180518214424/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2018-06-09T11:34:03Z', 'uri': 'http://web.archive.org/web/20180609113403/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}, {'datetime': '2018-07-12T18:30:43Z', 'uri': 'http://web.archive.org/web/20180712183043/https://www.guideline.gov/expert/expert-commentary/16451/a-season-for-change'}]
https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:15:59Z', 'uri': 'http://wayback.archive-it.org/all/20160930161559/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2016-09-30T16:15:59Z', 'uri': 'http://web.archive.org/web/20160930161559/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2017-07-14T11:22:37Z', 'uri': 'http://web.archive.org/web/20170714112237/https://guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2017-10-02T20:01:17Z', 'uri': 'http://wayback.archive-it.org/all/20171002200117/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2017-10-02T20:01:17Z', 'uri': 'http://web.archive.org/web/20171002200117/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2018-04-13T18:49:34Z', 'uri': 'http://wayback.archive-it.org/all/20180413184934/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2018-04-13T18:49:34Z', 'uri': 'http://web.archive.org/web/20180413184934/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2018-05-18T21:44:18Z', 'uri': 'http://wayback.archive-it.org/all/20180518214418/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2018-05-18T21:44:18Z', 'uri': 'http://web.archive.org/web/20180518214418/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2018-06-09T11:34:04Z', 'uri': 'http://web.archive.org/web/20180609113404/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}, {'datetime': '2018-07-12T18:30:38Z', 'uri': 'http://web.archive.org/web/20180712183038/https://www.guideline.gov/expert/expert-commentary/16452/diagnosis-and-treatment-of-low-back-pain-a-joint-clinical-practice-guideline-from-the-american-college-of-physicians-and-the-american-pain-society-whats-new-whats-different'}]
https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:35Z', 'uri': 'http://wayback.archive-it.org/all/20160930161435/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2016-09-30T16:14:35Z', 'uri': 'http://web.archive.org/web/20160930161435/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2017-07-14T11:01:51Z', 'uri': 'http://web.archive.org/web/20170714110151/https://guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2017-10-02T19:59:36Z', 'uri': 'http://wayback.archive-it.org/all/20171002195936/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2017-10-02T19:59:36Z', 'uri': 'http://web.archive.org/web/20171002195936/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2018-04-13T18:48:03Z', 'uri': 'http://wayback.archive-it.org/all/20180413184803/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2018-04-13T18:48:03Z', 'uri': 'http://web.archive.org/web/20180413184803/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2018-05-18T21:42:39Z', 'uri': 'http://wayback.archive-it.org/all/20180518214239/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2018-05-18T21:42:39Z', 'uri': 'http://web.archive.org/web/20180518214239/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2018-06-09T11:33:57Z', 'uri': 'http://web.archive.org/web/20180609113357/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}, {'datetime': '2018-07-12T18:30:41Z', 'uri': 'http://web.archive.org/web/20180712183041/https://www.guideline.gov/expert/expert-commentary/16474/new-directions-for-health-care-information-technology'}]
https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:31Z', 'uri': 'http://wayback.archive-it.org/all/20160930161431/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2016-09-30T16:14:31Z', 'uri': 'http://web.archive.org/web/20160930161431/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2017-07-14T11:05:07Z', 'uri': 'http://web.archive.org/web/20170714110507/https://guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2017-10-02T19:59:31Z', 'uri': 'http://wayback.archive-it.org/all/20171002195931/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2017-10-02T19:59:31Z', 'uri': 'http://web.archive.org/web/20171002195931/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2018-04-13T18:47:57Z', 'uri': 'http://wayback.archive-it.org/all/20180413184757/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2018-04-13T18:47:57Z', 'uri': 'http://web.archive.org/web/20180413184757/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2018-05-18T21:42:32Z', 'uri': 'http://wayback.archive-it.org/all/20180518214232/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2018-05-18T21:42:32Z', 'uri': 'http://web.archive.org/web/20180518214232/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2018-06-09T11:34:05Z', 'uri': 'http://web.archive.org/web/20180609113405/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}, {'datetime': '2018-07-12T18:31:52Z', 'uri': 'http://web.archive.org/web/20180712183152/https://www.guideline.gov/expert/expert-commentary/16475/applying-the-grade-approach-perspective-from-the-canadian-agency-for-drugs-and-technologies-in-health'}]
https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:25Z', 'uri': 'http://wayback.archive-it.org/all/20160930161425/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2016-09-30T16:14:25Z', 'uri': 'http://web.archive.org/web/20160930161425/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2017-07-14T10:28:49Z', 'uri': 'http://web.archive.org/web/20170714102849/https://guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2017-10-02T19:59:26Z', 'uri': 'http://wayback.archive-it.org/all/20171002195926/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2017-10-02T19:59:26Z', 'uri': 'http://web.archive.org/web/20171002195926/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2018-04-13T18:47:50Z', 'uri': 'http://wayback.archive-it.org/all/20180413184750/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2018-04-13T18:47:50Z', 'uri': 'http://web.archive.org/web/20180413184750/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2018-05-18T21:42:23Z', 'uri': 'http://wayback.archive-it.org/all/20180518214223/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2018-05-18T21:42:23Z', 'uri': 'http://web.archive.org/web/20180518214223/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2018-06-09T11:34:01Z', 'uri': 'http://web.archive.org/web/20180609113401/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}, {'datetime': '2018-07-12T18:31:38Z', 'uri': 'http://web.archive.org/web/20180712183138/https://www.guideline.gov/expert/expert-commentary/23793/an-integrated-approach-to-developing-health-care-guidelines-and-measures'}]
https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:20Z', 'uri': 'http://wayback.archive-it.org/all/20160930161420/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2016-09-30T16:14:20Z', 'uri': 'http://web.archive.org/web/20160930161420/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2017-07-14T09:58:46Z', 'uri': 'http://web.archive.org/web/20170714095846/https://guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2017-10-02T19:59:22Z', 'uri': 'http://wayback.archive-it.org/all/20171002195922/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2017-10-02T19:59:22Z', 'uri': 'http://web.archive.org/web/20171002195922/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2018-04-13T18:47:41Z', 'uri': 'http://wayback.archive-it.org/all/20180413184741/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2018-04-13T18:47:41Z', 'uri': 'http://web.archive.org/web/20180413184741/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2018-05-18T21:42:18Z', 'uri': 'http://wayback.archive-it.org/all/20180518214218/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2018-05-18T21:42:18Z', 'uri': 'http://web.archive.org/web/20180518214218/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2018-06-09T11:34:06Z', 'uri': 'http://web.archive.org/web/20180609113406/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}, {'datetime': '2018-07-12T18:31:22Z', 'uri': 'http://web.archive.org/web/20180712183122/https://www.guideline.gov/expert/expert-commentary/23795/recommendations-for-initiating-antiretroviral-therapy-reflect-need-for-further-research'}]
https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:15Z', 'uri': 'http://wayback.archive-it.org/all/20160930161415/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2016-09-30T16:14:15Z', 'uri': 'http://web.archive.org/web/20160930161415/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2017-07-14T10:44:57Z', 'uri': 'http://web.archive.org/web/20170714104457/https://guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2017-10-02T19:59:17Z', 'uri': 'http://wayback.archive-it.org/all/20171002195917/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2017-10-02T19:59:17Z', 'uri': 'http://web.archive.org/web/20171002195917/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2018-04-13T18:47:35Z', 'uri': 'http://wayback.archive-it.org/all/20180413184735/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2018-04-13T18:47:35Z', 'uri': 'http://web.archive.org/web/20180413184735/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2018-05-18T21:42:11Z', 'uri': 'http://wayback.archive-it.org/all/20180518214211/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2018-05-18T21:42:11Z', 'uri': 'http://web.archive.org/web/20180518214211/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2018-06-09T11:34:01Z', 'uri': 'http://web.archive.org/web/20180609113401/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}, {'datetime': '2018-07-12T18:31:06Z', 'uri': 'http://web.archive.org/web/20180712183106/https://www.guideline.gov/expert/expert-commentary/23796/focus-on-accessibility-results-in-improved-function-and-content-for-ngc-and-nqmc'}]
https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:05Z', 'uri': 'http://wayback.archive-it.org/all/20160930161405/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2016-09-30T16:14:05Z', 'uri': 'http://web.archive.org/web/20160930161405/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2017-07-14T11:30:34Z', 'uri': 'http://web.archive.org/web/20170714113034/https://guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2017-10-02T19:59:08Z', 'uri': 'http://wayback.archive-it.org/all/20171002195908/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2017-10-02T19:59:08Z', 'uri': 'http://web.archive.org/web/20171002195908/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2018-04-13T18:47:23Z', 'uri': 'http://wayback.archive-it.org/all/20180413184723/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2018-04-13T18:47:23Z', 'uri': 'http://web.archive.org/web/20180413184723/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2018-05-18T21:41:56Z', 'uri': 'http://wayback.archive-it.org/all/20180518214156/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2018-05-18T21:41:56Z', 'uri': 'http://web.archive.org/web/20180518214156/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2018-06-09T11:33:57Z', 'uri': 'http://web.archive.org/web/20180609113357/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}, {'datetime': '2018-07-12T18:31:36Z', 'uri': 'http://web.archive.org/web/20180712183136/https://www.guideline.gov/expert/expert-commentary/23991/does-more-add-up-to-less-a-review-of-a-guideline-on-whiplash-associated-disorders'}]
https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:14:01Z', 'uri': 'http://wayback.archive-it.org/all/20160930161401/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2016-09-30T16:14:01Z', 'uri': 'http://web.archive.org/web/20160930161401/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2017-07-14T11:20:36Z', 'uri': 'http://web.archive.org/web/20170714112036/https://guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2017-10-02T19:59:03Z', 'uri': 'http://wayback.archive-it.org/all/20171002195903/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2017-10-02T19:59:03Z', 'uri': 'http://web.archive.org/web/20171002195903/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2018-04-13T18:47:17Z', 'uri': 'http://wayback.archive-it.org/all/20180413184717/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2018-04-13T18:47:17Z', 'uri': 'http://web.archive.org/web/20180413184717/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2018-05-18T21:41:17Z', 'uri': 'http://wayback.archive-it.org/all/20180518214117/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2018-05-18T21:41:17Z', 'uri': 'http://web.archive.org/web/20180518214117/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2018-06-09T11:34:08Z', 'uri': 'http://web.archive.org/web/20180609113408/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}, {'datetime': '2018-07-12T18:30:39Z', 'uri': 'http://web.archive.org/web/20180712183039/https://www.guideline.gov/expert/expert-commentary/24283/managing-numerous-outcomes-experience-from-a-systematic-review-of-abnormal-uterine-bleeding-trials'}]
https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:56Z', 'uri': 'http://wayback.archive-it.org/all/20160930161356/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2016-09-30T16:13:56Z', 'uri': 'http://web.archive.org/web/20160930161356/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2017-07-14T10:12:20Z', 'uri': 'http://web.archive.org/web/20170714101220/https://guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2017-10-02T19:58:58Z', 'uri': 'http://wayback.archive-it.org/all/20171002195858/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2017-10-02T19:58:58Z', 'uri': 'http://web.archive.org/web/20171002195858/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2018-04-13T18:47:12Z', 'uri': 'http://wayback.archive-it.org/all/20180413184712/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2018-04-13T18:47:12Z', 'uri': 'http://web.archive.org/web/20180413184712/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2018-05-18T21:41:10Z', 'uri': 'http://wayback.archive-it.org/all/20180518214110/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2018-05-18T21:41:10Z', 'uri': 'http://web.archive.org/web/20180518214110/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2018-06-09T11:34:01Z', 'uri': 'http://web.archive.org/web/20180609113401/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}, {'datetime': '2018-07-12T18:31:01Z', 'uri': 'http://web.archive.org/web/20180712183101/https://www.guideline.gov/expert/expert-commentary/24556/promoting-transparent-and-actionable-clinical-practice-guidelines-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-ngcnqmc-editorial-board'}]
https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:52Z', 'uri': 'http://wayback.archive-it.org/all/20160930161352/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2016-09-30T16:13:52Z', 'uri': 'http://web.archive.org/web/20160930161352/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2017-07-14T11:06:14Z', 'uri': 'http://web.archive.org/web/20170714110614/https://guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2017-10-02T19:58:53Z', 'uri': 'http://wayback.archive-it.org/all/20171002195853/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2017-10-02T19:58:53Z', 'uri': 'http://web.archive.org/web/20171002195853/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2018-04-13T18:47:07Z', 'uri': 'http://wayback.archive-it.org/all/20180413184707/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2018-04-13T18:47:07Z', 'uri': 'http://web.archive.org/web/20180413184707/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2018-05-18T21:41:05Z', 'uri': 'http://wayback.archive-it.org/all/20180518214105/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2018-05-18T21:41:05Z', 'uri': 'http://web.archive.org/web/20180518214105/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2018-06-09T11:33:59Z', 'uri': 'http://web.archive.org/web/20180609113359/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}, {'datetime': '2018-07-12T18:31:47Z', 'uri': 'http://web.archive.org/web/20180712183147/https://www.guideline.gov/expert/expert-commentary/25636/updated-evidence-and-safety-focus-keep-guidance-on-laparoscopic-biliary-tract-surgery-current'}]
https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:47Z', 'uri': 'http://wayback.archive-it.org/all/20160930161347/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2016-09-30T16:13:47Z', 'uri': 'http://web.archive.org/web/20160930161347/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2017-07-14T10:16:03Z', 'uri': 'http://web.archive.org/web/20170714101603/https://guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2017-10-02T19:58:46Z', 'uri': 'http://wayback.archive-it.org/all/20171002195846/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2017-10-02T19:58:46Z', 'uri': 'http://web.archive.org/web/20171002195846/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2018-04-13T18:47:02Z', 'uri': 'http://wayback.archive-it.org/all/20180413184702/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2018-04-13T18:47:02Z', 'uri': 'http://web.archive.org/web/20180413184702/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2018-05-18T21:40:59Z', 'uri': 'http://wayback.archive-it.org/all/20180518214059/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2018-05-18T21:40:59Z', 'uri': 'http://web.archive.org/web/20180518214059/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2018-06-09T11:34:02Z', 'uri': 'http://web.archive.org/web/20180609113402/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}, {'datetime': '2018-07-12T18:30:55Z', 'uri': 'http://web.archive.org/web/20180712183055/https://www.guideline.gov/expert/expert-commentary/32972/auas-surgical-management-of-female-stress-urinary-incontinence-provides-timely-update'}]
https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:42Z', 'uri': 'http://wayback.archive-it.org/all/20160930161342/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2016-09-30T16:13:42Z', 'uri': 'http://web.archive.org/web/20160930161342/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2017-07-14T11:12:05Z', 'uri': 'http://web.archive.org/web/20170714111205/https://guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2017-10-02T19:58:42Z', 'uri': 'http://wayback.archive-it.org/all/20171002195842/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2017-10-02T19:58:42Z', 'uri': 'http://web.archive.org/web/20171002195842/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2018-04-13T18:46:56Z', 'uri': 'http://wayback.archive-it.org/all/20180413184656/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2018-04-13T18:46:56Z', 'uri': 'http://web.archive.org/web/20180413184656/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2018-05-18T21:40:52Z', 'uri': 'http://wayback.archive-it.org/all/20180518214052/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2018-05-18T21:40:52Z', 'uri': 'http://web.archive.org/web/20180518214052/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2018-06-09T11:34:00Z', 'uri': 'http://web.archive.org/web/20180609113400/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}, {'datetime': '2018-07-12T18:30:50Z', 'uri': 'http://web.archive.org/web/20180712183050/https://www.guideline.gov/expert/expert-commentary/35107/consensusbased-selection-criteria-for-accountability-measures-viewpoint-from-the-national-guideline-clearinghousenational-quality-measures-clearinghouse-editorial-board'}]
https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:37Z', 'uri': 'http://wayback.archive-it.org/all/20160930161337/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2016-09-30T16:13:37Z', 'uri': 'http://web.archive.org/web/20160930161337/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2017-07-14T11:19:26Z', 'uri': 'http://web.archive.org/web/20170714111926/https://guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2017-10-02T19:58:37Z', 'uri': 'http://wayback.archive-it.org/all/20171002195837/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2017-10-02T19:58:37Z', 'uri': 'http://web.archive.org/web/20171002195837/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2018-04-13T18:46:51Z', 'uri': 'http://wayback.archive-it.org/all/20180413184651/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2018-04-13T18:46:51Z', 'uri': 'http://web.archive.org/web/20180413184651/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2018-05-18T21:40:46Z', 'uri': 'http://wayback.archive-it.org/all/20180518214046/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2018-05-18T21:40:46Z', 'uri': 'http://web.archive.org/web/20180518214046/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2018-06-09T11:34:05Z', 'uri': 'http://web.archive.org/web/20180609113405/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}, {'datetime': '2018-07-12T18:31:43Z', 'uri': 'http://web.archive.org/web/20180712183143/https://www.guideline.gov/expert/expert-commentary/36835/primary-care-depression-guidelines-and-treatment-resistant-depression-variations-on-an-important-but-understudied-theme'}]
https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:33Z', 'uri': 'http://wayback.archive-it.org/all/20160930161333/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2016-09-30T16:13:33Z', 'uri': 'http://web.archive.org/web/20160930161333/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2017-07-14T11:24:43Z', 'uri': 'http://web.archive.org/web/20170714112443/https://guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2017-10-02T19:58:32Z', 'uri': 'http://wayback.archive-it.org/all/20171002195832/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2017-10-02T19:58:32Z', 'uri': 'http://web.archive.org/web/20171002195832/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2018-04-13T18:46:46Z', 'uri': 'http://wayback.archive-it.org/all/20180413184646/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2018-04-13T18:46:46Z', 'uri': 'http://web.archive.org/web/20180413184646/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2018-05-18T21:40:41Z', 'uri': 'http://wayback.archive-it.org/all/20180518214041/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2018-05-18T21:40:41Z', 'uri': 'http://web.archive.org/web/20180518214041/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2018-06-09T11:34:04Z', 'uri': 'http://web.archive.org/web/20180609113404/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}, {'datetime': '2018-07-12T18:31:12Z', 'uri': 'http://web.archive.org/web/20180712183112/https://www.guideline.gov/expert/expert-commentary/36907/imaging-after-initial-urinary-tract-infection-uti-in-febrile-infants-and-young-children-a-paradigm-shift'}]
https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:28Z', 'uri': 'http://wayback.archive-it.org/all/20160930161328/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2016-09-30T16:13:28Z', 'uri': 'http://web.archive.org/web/20160930161328/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2017-07-14T11:00:21Z', 'uri': 'http://web.archive.org/web/20170714110021/https://guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2017-10-02T19:58:28Z', 'uri': 'http://wayback.archive-it.org/all/20171002195828/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2017-10-02T19:58:28Z', 'uri': 'http://web.archive.org/web/20171002195828/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2018-04-13T18:46:40Z', 'uri': 'http://wayback.archive-it.org/all/20180413184640/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2018-04-13T18:46:40Z', 'uri': 'http://web.archive.org/web/20180413184640/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2018-05-18T21:40:36Z', 'uri': 'http://wayback.archive-it.org/all/20180518214036/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2018-05-18T21:40:36Z', 'uri': 'http://web.archive.org/web/20180518214036/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2018-06-09T11:34:00Z', 'uri': 'http://web.archive.org/web/20180609113400/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}, {'datetime': '2018-07-12T18:31:18Z', 'uri': 'http://web.archive.org/web/20180712183118/https://www.guideline.gov/expert/expert-commentary/37561/eliminating-hospital-readmissions-no-hospital-left-behind'}]
https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:23Z', 'uri': 'http://wayback.archive-it.org/all/20160930161323/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2016-09-30T16:13:23Z', 'uri': 'http://web.archive.org/web/20160930161323/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2017-07-14T10:27:33Z', 'uri': 'http://web.archive.org/web/20170714102733/https://guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2017-10-02T19:58:22Z', 'uri': 'http://wayback.archive-it.org/all/20171002195822/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2017-10-02T19:58:22Z', 'uri': 'http://web.archive.org/web/20171002195822/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2018-04-13T18:46:35Z', 'uri': 'http://wayback.archive-it.org/all/20180413184635/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2018-04-13T18:46:35Z', 'uri': 'http://web.archive.org/web/20180413184635/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2018-05-18T21:40:30Z', 'uri': 'http://wayback.archive-it.org/all/20180518214030/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2018-05-18T21:40:30Z', 'uri': 'http://web.archive.org/web/20180518214030/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2018-06-09T11:33:58Z', 'uri': 'http://web.archive.org/web/20180609113358/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}, {'datetime': '2018-07-12T18:31:15Z', 'uri': 'http://web.archive.org/web/20180712183115/https://www.guideline.gov/expert/expert-commentary/37828/management-of-hemorrhoids-mainstay-of-treatment-remains-diet-modification-and-officebased-procedures'}]
https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:18Z', 'uri': 'http://wayback.archive-it.org/all/20160930161318/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2016-09-30T16:13:18Z', 'uri': 'http://web.archive.org/web/20160930161318/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2017-07-14T11:17:28Z', 'uri': 'http://web.archive.org/web/20170714111728/https://guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2017-10-02T19:58:16Z', 'uri': 'http://wayback.archive-it.org/all/20171002195816/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2017-10-02T19:58:16Z', 'uri': 'http://web.archive.org/web/20171002195816/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2018-04-13T18:46:29Z', 'uri': 'http://wayback.archive-it.org/all/20180413184629/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2018-04-13T18:46:29Z', 'uri': 'http://web.archive.org/web/20180413184629/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2018-05-18T21:40:23Z', 'uri': 'http://wayback.archive-it.org/all/20180518214023/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2018-05-18T21:40:23Z', 'uri': 'http://web.archive.org/web/20180518214023/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2018-06-09T11:34:03Z', 'uri': 'http://web.archive.org/web/20180609113403/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}, {'datetime': '2018-07-12T18:30:52Z', 'uri': 'http://web.archive.org/web/20180712183052/https://www.guideline.gov/expert/expert-commentary/37872/recommendations-for-initiating-antiretroviral-therapy-reflect-return-to-earlier-treatment-methods'}]
https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:13Z', 'uri': 'http://wayback.archive-it.org/all/20160930161313/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2016-09-30T16:13:13Z', 'uri': 'http://web.archive.org/web/20160930161313/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2017-07-14T10:15:31Z', 'uri': 'http://web.archive.org/web/20170714101531/https://guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2017-10-02T19:58:10Z', 'uri': 'http://wayback.archive-it.org/all/20171002195810/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2017-10-02T19:58:10Z', 'uri': 'http://web.archive.org/web/20171002195810/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2018-04-13T18:46:25Z', 'uri': 'http://wayback.archive-it.org/all/20180413184625/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2018-04-13T18:46:25Z', 'uri': 'http://web.archive.org/web/20180413184625/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2018-05-18T21:40:18Z', 'uri': 'http://wayback.archive-it.org/all/20180518214018/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2018-05-18T21:40:18Z', 'uri': 'http://web.archive.org/web/20180518214018/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2018-06-09T11:34:00Z', 'uri': 'http://web.archive.org/web/20180609113400/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}, {'datetime': '2018-07-12T18:31:20Z', 'uri': 'http://web.archive.org/web/20180712183120/https://www.guideline.gov/expert/expert-commentary/38577/importance-of-quality-metrics-for-providing-high-quality-melanoma-care'}]
https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:13:08Z', 'uri': 'http://wayback.archive-it.org/all/20160930161308/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2016-09-30T16:13:08Z', 'uri': 'http://web.archive.org/web/20160930161308/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2017-07-14T10:59:55Z', 'uri': 'http://web.archive.org/web/20170714105955/https://guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2017-10-02T19:58:02Z', 'uri': 'http://wayback.archive-it.org/all/20171002195802/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2017-10-02T19:58:02Z', 'uri': 'http://web.archive.org/web/20171002195802/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2018-04-13T18:46:20Z', 'uri': 'http://wayback.archive-it.org/all/20180413184620/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2018-04-13T18:46:20Z', 'uri': 'http://web.archive.org/web/20180413184620/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2018-05-18T21:40:12Z', 'uri': 'http://wayback.archive-it.org/all/20180518214012/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2018-05-18T21:40:12Z', 'uri': 'http://web.archive.org/web/20180518214012/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2018-06-09T11:34:08Z', 'uri': 'http://web.archive.org/web/20180609113408/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}, {'datetime': '2018-07-12T18:31:54Z', 'uri': 'http://web.archive.org/web/20180712183154/https://www.guideline.gov/expert/expert-commentary/39252/colorectal-cancer-guideline-reflects-international-practice-variations'}]
https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:09:43Z', 'uri': 'http://wayback.archive-it.org/all/20160930160943/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2016-09-30T16:09:43Z', 'uri': 'http://web.archive.org/web/20160930160943/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2017-07-14T11:07:31Z', 'uri': 'http://web.archive.org/web/20170714110731/https://guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2017-10-02T19:57:57Z', 'uri': 'http://wayback.archive-it.org/all/20171002195757/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2017-10-02T19:57:57Z', 'uri': 'http://web.archive.org/web/20171002195757/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2018-04-13T18:46:14Z', 'uri': 'http://wayback.archive-it.org/all/20180413184614/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2018-04-13T18:46:14Z', 'uri': 'http://web.archive.org/web/20180413184614/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2018-05-18T21:40:05Z', 'uri': 'http://wayback.archive-it.org/all/20180518214005/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2018-05-18T21:40:05Z', 'uri': 'http://web.archive.org/web/20180518214005/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2018-06-09T11:33:58Z', 'uri': 'http://web.archive.org/web/20180609113358/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}, {'datetime': '2018-07-12T18:30:58Z', 'uri': 'http://web.archive.org/web/20180712183058/https://www.guideline.gov/expert/expert-commentary/43901/treat-the-system-not-the-error-patient-safety-in-2013'}]
https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:09:39Z', 'uri': 'http://wayback.archive-it.org/all/20160930160939/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2016-09-30T16:09:39Z', 'uri': 'http://web.archive.org/web/20160930160939/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2017-07-14T11:13:35Z', 'uri': 'http://web.archive.org/web/20170714111335/https://guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2017-10-02T19:57:52Z', 'uri': 'http://wayback.archive-it.org/all/20171002195752/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2017-10-02T19:57:52Z', 'uri': 'http://web.archive.org/web/20171002195752/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2018-04-13T18:46:09Z', 'uri': 'http://wayback.archive-it.org/all/20180413184609/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2018-04-13T18:46:09Z', 'uri': 'http://web.archive.org/web/20180413184609/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2018-05-18T21:40:00Z', 'uri': 'http://wayback.archive-it.org/all/20180518214000/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2018-05-18T21:40:00Z', 'uri': 'http://web.archive.org/web/20180518214000/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2018-06-09T11:34:06Z', 'uri': 'http://web.archive.org/web/20180609113406/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}, {'datetime': '2018-07-12T18:30:44Z', 'uri': 'http://web.archive.org/web/20180712183044/https://www.guideline.gov/expert/expert-commentary/43913/a-perspective-on-the-guidelines-international-network-and-the-institute-of-medicines-proposed-standards-for-guideline-development'}]
https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth	ARCHIVED	11 mementos	[{'datetime': '2016-09-30T16:09:29Z', 'uri': 'http://wayback.archive-it.org/all/20160930160929/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2016-09-30T16:09:29Z', 'uri': 'http://web.archive.org/web/20160930160929/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2017-07-14T09:54:57Z', 'uri': 'http://web.archive.org/web/20170714095457/https://guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2017-10-02T19:57:40Z', 'uri': 'http://wayback.archive-it.org/all/20171002195740/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2017-10-02T19:57:40Z', 'uri': 'http://web.archive.org/web/20171002195740/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2018-04-13T18:45:57Z', 'uri': 'http://wayback.archive-it.org/all/20180413184557/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2018-04-13T18:45:57Z', 'uri': 'http://web.archive.org/web/20180413184557/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2018-05-18T21:38:54Z', 'uri': 'http://wayback.archive-it.org/all/20180518213854/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2018-05-18T21:38:54Z', 'uri': 'http://web.archive.org/web/20180518213854/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2018-06-09T11:34:00Z', 'uri': 'http://web.archive.org/web/20180609113400/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}, {'datetime': '2018-07-12T18:31:26Z', 'uri': 'http://web.archive.org/web/20180712183126/https://www.guideline.gov/expert/expert-commentary/46658/ngc-and-nqmc-survey-responses-generate-enhancement-and-growth'}]
https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference	ARCHIVED	13 mementos	[{'datetime': '2016-09-30T16:09:20Z', 'uri': 'http://wayback.archive-it.org/all/20160930160920/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2016-09-30T16:09:20Z', 'uri': 'http://web.archive.org/web/20160930160920/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2017-07-14T09:50:19Z', 'uri': 'http://web.archive.org/web/20170714095019/https://guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2017-10-02T19:57:30Z', 'uri': 'http://wayback.archive-it.org/all/20171002195730/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2017-10-02T19:57:30Z', 'uri': 'http://web.archive.org/web/20171002195730/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-04-13T18:45:45Z', 'uri': 'http://wayback.archive-it.org/all/20180413184545/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-04-13T18:45:45Z', 'uri': 'http://web.archive.org/web/20180413184545/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-05-18T21:38:38Z', 'uri': 'http://wayback.archive-it.org/all/20180518213838/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-05-18T21:38:38Z', 'uri': 'http://web.archive.org/web/20180518213838/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-06-09T11:34:09Z', 'uri': 'http://web.archive.org/web/20180609113409/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-07-12T18:31:24Z', 'uri': 'http://web.archive.org/web/20180712183124/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-07-12T21:08:05Z', 'uri': 'http://web.archive.org/web/20180712210805/http://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}, {'datetime': '2018-07-12T21:08:06Z', 'uri': 'http://web.archive.org/web/20180712210806/https://www.guideline.gov/expert/expert-commentary/49012/reflections-from-the-2014-guidelines-international-network-conference'}]
https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement	ARCHIVED	13 mementos	[{'datetime': '2016-09-30T16:09:16Z', 'uri': 'http://wayback.archive-it.org/all/20160930160916/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2016-09-30T16:09:16Z', 'uri': 'http://web.archive.org/web/20160930160916/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2017-07-14T10:22:33Z', 'uri': 'http://web.archive.org/web/20170714102233/https://guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2017-10-02T19:57:25Z', 'uri': 'http://wayback.archive-it.org/all/20171002195725/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2017-10-02T19:57:25Z', 'uri': 'http://web.archive.org/web/20171002195725/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-04-13T18:45:39Z', 'uri': 'http://wayback.archive-it.org/all/20180413184539/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-04-13T18:45:39Z', 'uri': 'http://web.archive.org/web/20180413184539/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-05-18T21:38:30Z', 'uri': 'http://wayback.archive-it.org/all/20180518213830/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-05-18T21:38:30Z', 'uri': 'http://web.archive.org/web/20180518213830/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-06-09T11:34:07Z', 'uri': 'http://web.archive.org/web/20180609113407/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-07-12T18:30:48Z', 'uri': 'http://web.archive.org/web/20180712183048/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-07-12T21:08:04Z', 'uri': 'http://web.archive.org/web/20180712210804/http://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}, {'datetime': '2018-07-12T21:08:05Z', 'uri': 'http://web.archive.org/web/20180712210805/https://www.guideline.gov/expert/expert-commentary/49252/aligning-guidelines-with-the-iom-standards-a-perspective-from-the-institute-for-clinical-systems-improvement'}]
https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking	ARCHIVED	14 mementos	[{'datetime': '2016-09-30T16:09:11Z', 'uri': 'http://wayback.archive-it.org/all/20160930160911/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2016-09-30T16:09:11Z', 'uri': 'http://web.archive.org/web/20160930160911/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2017-07-14T10:53:09Z', 'uri': 'http://web.archive.org/web/20170714105309/https://guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2017-10-02T19:57:20Z', 'uri': 'http://wayback.archive-it.org/all/20171002195720/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2017-10-02T19:57:20Z', 'uri': 'http://web.archive.org/web/20171002195720/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-04-13T18:45:32Z', 'uri': 'http://wayback.archive-it.org/all/20180413184532/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-04-13T18:45:32Z', 'uri': 'http://web.archive.org/web/20180413184532/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-05-17T20:23:23Z', 'uri': 'http://web.archive.org/web/20180517202323/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-05-18T21:38:24Z', 'uri': 'http://wayback.archive-it.org/all/20180518213824/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-05-18T21:38:24Z', 'uri': 'http://web.archive.org/web/20180518213824/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-06-09T11:34:07Z', 'uri': 'http://web.archive.org/web/20180609113407/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-07-12T18:30:47Z', 'uri': 'http://web.archive.org/web/20180712183047/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-07-12T21:08:01Z', 'uri': 'http://web.archive.org/web/20180712210801/http://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}, {'datetime': '2018-07-12T21:08:02Z', 'uri': 'http://web.archive.org/web/20180712210802/https://www.guideline.gov/expert/expert-commentary/49423/implementing-guidelines-in-your-organization-what-questions-should-you-be-asking'}]
https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions	ARCHIVED	13 mementos	[{'datetime': '2016-09-30T16:09:05Z', 'uri': 'http://wayback.archive-it.org/all/20160930160905/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2016-09-30T16:09:05Z', 'uri': 'http://web.archive.org/web/20160930160905/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2017-07-14T11:16:59Z', 'uri': 'http://web.archive.org/web/20170714111659/https://guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2017-10-02T19:57:13Z', 'uri': 'http://wayback.archive-it.org/all/20171002195713/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2017-10-02T19:57:13Z', 'uri': 'http://web.archive.org/web/20171002195713/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-04-13T18:45:25Z', 'uri': 'http://wayback.archive-it.org/all/20180413184525/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-04-13T18:45:25Z', 'uri': 'http://web.archive.org/web/20180413184525/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-05-18T21:38:17Z', 'uri': 'http://wayback.archive-it.org/all/20180518213817/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-05-18T21:38:17Z', 'uri': 'http://web.archive.org/web/20180518213817/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-06-09T11:34:04Z', 'uri': 'http://web.archive.org/web/20180609113404/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-07-12T18:30:51Z', 'uri': 'http://web.archive.org/web/20180712183051/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-07-12T21:08:00Z', 'uri': 'http://web.archive.org/web/20180712210800/http://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}, {'datetime': '2018-07-12T21:08:01Z', 'uri': 'http://web.archive.org/web/20180712210801/https://www.guideline.gov/expert/expert-commentary/49880/extending-the-applicability-of-clinical-practice-guidelines-to-patients-with-multiple-chronic-conditions'}]
https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care	ARCHIVED	9 mementos	[{'datetime': '2017-07-14T11:10:29Z', 'uri': 'http://web.archive.org/web/20170714111029/https://guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2017-10-02T19:59:13Z', 'uri': 'http://wayback.archive-it.org/all/20171002195913/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2017-10-02T19:59:13Z', 'uri': 'http://web.archive.org/web/20171002195913/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2018-04-13T18:47:30Z', 'uri': 'http://wayback.archive-it.org/all/20180413184730/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2018-04-13T18:47:30Z', 'uri': 'http://web.archive.org/web/20180413184730/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2018-05-18T21:42:04Z', 'uri': 'http://wayback.archive-it.org/all/20180518214204/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2018-05-18T21:42:04Z', 'uri': 'http://web.archive.org/web/20180518214204/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2018-06-09T11:33:59Z', 'uri': 'http://web.archive.org/web/20180609113359/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}, {'datetime': '2018-07-12T18:31:55Z', 'uri': 'http://web.archive.org/web/20180712183155/https://www.guideline.gov/expert/expert-commentary/50621/surmounting-the-challenges-of-measuring-and-improving-quality-in-ambulatory-care'}]
https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria	ARCHIVED	9 mementos	[{'datetime': '2017-07-14T10:48:02Z', 'uri': 'http://web.archive.org/web/20170714104802/https://guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2017-10-02T19:57:35Z', 'uri': 'http://wayback.archive-it.org/all/20171002195735/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2017-10-02T19:57:35Z', 'uri': 'http://web.archive.org/web/20171002195735/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2018-04-13T18:45:51Z', 'uri': 'http://wayback.archive-it.org/all/20180413184551/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2018-04-13T18:45:51Z', 'uri': 'http://web.archive.org/web/20180413184551/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2018-05-18T21:38:45Z', 'uri': 'http://wayback.archive-it.org/all/20180518213845/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2018-05-18T21:38:45Z', 'uri': 'http://web.archive.org/web/20180518213845/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2018-06-09T11:34:02Z', 'uri': 'http://web.archive.org/web/20180609113402/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}, {'datetime': '2018-07-12T18:30:34Z', 'uri': 'http://web.archive.org/web/20180712183034/https://www.guideline.gov/expert/expert-commentary/50780/introducing-the-national-guideline-clearinghouse-revised-inclusion-criteria'}]
https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going	ARCHIVED	12 mementos	[{'datetime': '2017-10-02T19:57:08Z', 'uri': 'http://wayback.archive-it.org/all/20171002195708/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2017-10-02T19:57:08Z', 'uri': 'http://web.archive.org/web/20171002195708/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-04-13T18:45:19Z', 'uri': 'http://wayback.archive-it.org/all/20180413184519/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-04-13T18:45:19Z', 'uri': 'http://web.archive.org/web/20180413184519/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-05-18T21:38:10Z', 'uri': 'http://wayback.archive-it.org/all/20180518213810/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-05-18T21:38:10Z', 'uri': 'http://web.archive.org/web/20180518213810/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-06-09T11:34:07Z', 'uri': 'http://web.archive.org/web/20180609113407/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-07-12T18:30:47Z', 'uri': 'http://web.archive.org/web/20180712183047/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-07-12T21:07:57Z', 'uri': 'http://web.archive.org/web/20180712210757/http://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-07-12T21:07:58Z', 'uri': 'http://web.archive.org/web/20180712210758/https://www.guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-07-14T20:43:50Z', 'uri': 'http://web.archive.org/web/20180714204350/https://guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}, {'datetime': '2018-07-14T20:43:50Z', 'uri': 'http://web.archive.org/web/20180714204350/https://guideline.gov/expert/expert-commentary/51039/treating-chronic-painwhere-we-have-been-and-where-we-are-going'}]
